PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology, Siddha Central Research Institute, Central Council for Research in Siddha, Ministry of AYUSH, Govt. of India, Anna Hospital Campus, Arumbakkam, Chennai-106, India. Electronic address: lalpharm78@gmail.com.\', \'Department of Genetic Toxicology, Microbiology and In Vitro Toxicology, Eurofins Advinus, Phase 21 & 22, Bangalore-560 058, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1094-5539(20)30183-810.1016/j.pupt.2020.101978
?:hasPublicationType
?:journal
  • Pulmonary pharmacology & therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33259924
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33259924>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33259924>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all